Dritan Keta

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Gjin Ndrepepa, Klaus Tiroch, Massimiliano Fusaro et al. · Journal of the American College of Cardiology · 2010 · 469 citations

Medicine, Cardiology, Internal Medicine +13

Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Gjin Ndrepepa, Klaus Tiroch, Dritan Keta et al. · Circulation Cardiovascular Interventions · 2010 · 177 citations

Medicine, Cardiology, Internal Medicine +14

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

S. Schulz, Gert Richardt, Karl‐Ludwig Laugwitz et al. · European Heart Journal · 2014 · 109 citations

Medicine, Cardiology, Pharmacotherapy +17

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

Gjin Ndrepepa, Julinda Mehilli, S. Schulz et al. · Journal of the American College of Cardiology · 2008 · 88 citations

Medicine, Cardiology, Clinical Sciences +16